BRIEF-Xlife Sciences AG Says Veraxa Biotech AG To Merge With Voyager Acquisition Corp.

Reuters

23 Apr

BRIEF-Xlife Sciences AG Says Veraxa Biotech AG To Merge With <a href="https://laohu8.com/S/VACH">Voyager Acquisition Corp</a>.

April 23 (Reuters) - Xlife Sciences AG XLS.S:

FROM LAB TO UNICORN: XLIFE SCIENCES AG PORTFOLIO COMPANY VERAXA BIOTECH AG TO MERGE WITH VOYAGER ACQUISITION CORP. LISTED ON NASDAQ
XLIFE SCIENCES AG - TRANSACTION VALUES VERAXA BIOTECH AT USD 1.64 BILLION
XLIFE SCIENCES AG - VERAXA SHAREHOLDERS TO RECEIVE 130 MILLION SHARES
XLIFE SCIENCES AG - BUSINESS COMBINATION EXPECTED TO CLOSE IN Q4 2025
XLIFE SCIENCES AG - VERAXA TO BE LISTED ON NASDAQ UNDER TICKER SYMBOL VERX
XLIFE SCIENCES AG - VERAXA IS RAISING A CROSSOVER FINANCING ROUND FROM NEW AND EXISTING INVESTORS
XLIFE SCIENCES - PROCEEDS ARE EXPECTED TO PROVIDE CAPITAL FOR AT LEAST TWO YEARS AND SUPPORT PURSUIT OF KEY PARTNERSHIPS; CO-DEVELOPMENT OPPORTUNITIES

Source text: ID:nEQ4z6W6ba

Further company coverage: XLS.S

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2529839548"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2529839548\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2529839548?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-23 13:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2529839548","market":"us","top_or_hot":-1,"title":"BRIEF-Xlife Sciences AG Says Veraxa Biotech AG To Merge With Voyager Acquisition Corp.","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Xlife Sciences AG Says Veraxa Biotech AG To Merge With <a href=\"https://laohu8.com/S/VACH\">Voyager Acquisition Corp</a>. </title></head><body><p><span>April 23 (Reuters)</span><span> - </span>Xlife Sciences AG <span>XLS.S</span>:</p><ul><li><p>FROM LAB TO UNICORN: XLIFE SCIENCES AG PORTFOLIO COMPANY VERAXA BIOTECH AG TO MERGE WITH VOYAGER ACQUISITION CORP. LISTED ON NASDAQ</p></li><li><p>XLIFE SCIENCES AG - TRANSACTION VALUES VERAXA BIOTECH AT USD 1.64 BILLION</p></li><li><p>XLIFE SCIENCES AG - VERAXA SHAREHOLDERS TO RECEIVE 130 MILLION SHARES</p></li><li><p>XLIFE SCIENCES AG - BUSINESS COMBINATION EXPECTED TO CLOSE IN Q4 2025</p></li><li><p>XLIFE SCIENCES AG - VERAXA TO BE LISTED ON NASDAQ UNDER TICKER SYMBOL VERX</p></li><li><p>XLIFE SCIENCES AG - VERAXA IS RAISING A CROSSOVER FINANCING ROUND FROM NEW AND EXISTING INVESTORS</p></li><li><p>XLIFE SCIENCES - PROCEEDS ARE EXPECTED TO PROVIDE CAPITAL FOR AT LEAST TWO YEARS AND SUPPORT PURSUIT OF KEY PARTNERSHIPS; CO-DEVELOPMENT OPPORTUNITIES</p></li></ul><p>Source text: <span>ID:nEQ4z6W6ba</span></p><p>Further company coverage: <span>XLS.S</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Xlife Sciences AG Says Veraxa Biotech AG To Merge With Voyager Acquisition Corp.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Xlife Sciences AG Says Veraxa Biotech AG To Merge With Voyager Acquisition Corp.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-04-23 13:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Xlife Sciences AG Says Veraxa Biotech AG To Merge With <a href=\"https://laohu8.com/S/VACH\">Voyager Acquisition Corp</a>. </title></head><body><p><span>April 23 (Reuters)</span><span> - </span>Xlife Sciences AG <span>XLS.S</span>:</p><ul><li><p>FROM LAB TO UNICORN: XLIFE SCIENCES AG PORTFOLIO COMPANY VERAXA BIOTECH AG TO MERGE WITH VOYAGER ACQUISITION CORP. LISTED ON NASDAQ</p></li><li><p>XLIFE SCIENCES AG - TRANSACTION VALUES VERAXA BIOTECH AT USD 1.64 BILLION</p></li><li><p>XLIFE SCIENCES AG - VERAXA SHAREHOLDERS TO RECEIVE 130 MILLION SHARES</p></li><li><p>XLIFE SCIENCES AG - BUSINESS COMBINATION EXPECTED TO CLOSE IN Q4 2025</p></li><li><p>XLIFE SCIENCES AG - VERAXA TO BE LISTED ON NASDAQ UNDER TICKER SYMBOL VERX</p></li><li><p>XLIFE SCIENCES AG - VERAXA IS RAISING A CROSSOVER FINANCING ROUND FROM NEW AND EXISTING INVESTORS</p></li><li><p>XLIFE SCIENCES - PROCEEDS ARE EXPECTED TO PROVIDE CAPITAL FOR AT LEAST TWO YEARS AND SUPPORT PURSUIT OF KEY PARTNERSHIPS; CO-DEVELOPMENT OPPORTUNITIES</p></li></ul><p>Source text: <span>ID:nEQ4z6W6ba</span></p><p>Further company coverage: <span>XLS.S</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VACH","symbol_name":"Voyager Acquisition Corp","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nTUC1RG50C:1","article_id":"2529839548","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2529839548","pubTimestamp":1745384847,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Xlife Sciences AG Says Veraxa Biotech AG To Merge With Voyager Acquisition Corp. April 23 (Reuters) - Xlife Sciences AG XLS.S:FROM LAB TO UNICORN: XLIFE SCIENCES AG PORTFOLIO COMPANY VERAXA BIOT","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VACH":"Voyager Acquisition Corp"},"translate_title":"简介-Xlife Sciences AG表示Veraxa Biotech AG将与Voyager Acquisition Corp合并。","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VACH":0.9},"content_text":"BRIEF-Xlife Sciences AG Says Veraxa Biotech AG To Merge With Voyager Acquisition Corp. April 23 (Reuters) - Xlife Sciences AG XLS.S:FROM LAB TO UNICORN: XLIFE SCIENCES AG PORTFOLIO COMPANY VERAXA BIOTECH AG TO MERGE WITH VOYAGER ACQUISITION CORP. LISTED ON NASDAQXLIFE SCIENCES AG - TRANSACTION VALUES VERAXA BIOTECH AT USD 1.64 BILLIONXLIFE SCIENCES AG - VERAXA SHAREHOLDERS TO RECEIVE 130 MILLION SHARESXLIFE SCIENCES AG - BUSINESS COMBINATION EXPECTED TO CLOSE IN Q4 2025XLIFE SCIENCES AG - VERAXA TO BE LISTED ON NASDAQ UNDER TICKER SYMBOL VERXXLIFE SCIENCES AG - VERAXA IS RAISING A CROSSOVER FINANCING ROUND FROM NEW AND EXISTING INVESTORSXLIFE SCIENCES - PROCEEDS ARE EXPECTED TO PROVIDE CAPITAL FOR AT LEAST TWO YEARS AND SUPPORT PURSUIT OF KEY PARTNERSHIPS; CO-DEVELOPMENT OPPORTUNITIESSource text: ID:nEQ4z6W6baFurther company coverage: XLS.S ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,merge","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}